<DOC>
	<DOCNO>NCT00779129</DOCNO>
	<brief_summary>Women metastatic breast cancer usually treat anthracyclines ( ie , doxorubicin epirubicin ) cardiac toxicity limit use . The aim study evaluate safety efficacy Caelyx combination cyclophosphamide woman metastatic breast cancer receive adjuvant anthracyclines without taxane .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Caelyx Combination With Cyclophosphamide Treatment Metastatic Breast Cancer ( P02948 )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Female , age &gt; =18 year . Subject must histologic diagnosis breast carcinoma . Subject must document measurable metastatic breast cancer appropriate radiologic imaging . Subject must previous anthracyclinbased adjuvant regimen diseasefree status least one year follow completion adjuvant therapy . Subject must ECOG performance status 0 , 1 , 2 . Subject must life expectancy &gt; 6 month Subject must leave ventricular ejection fraction &gt; =55 % determine MUGA scan . Subject must normal organ function , except abnormal due tumor involvement : Adequate bone marrow function ( platelet &gt; =100 X 10^9/L , hemoglobin &gt; =90 g/L , Neutrophils &gt; =1.5 X 10^9/L ) Adequate renal function ( serum creatinine &lt; 2 X upper limit normal ( ULN ) Adequate liver function ( bilirubin &lt; 2 time ULN , AST ALT &lt; 2 time ULN absence liver metastasis , AST ALT &lt; 5 time ULN presence liver metastasis . Women childbearing potential must use adequate contraception negative pregnancy test time enrollment . Subject must able understand give informed consent . Age &gt; 75 year old . Subject pregnant breastfeeding unwilling use adequate contraception . Subject previous chemotherapy metastatic disease . Subject history cardiac disease , New York Heart Association Class II great congestive heart failure . Subject clinically significant hepatic disease regard Hepatitis B , Hepatitis C , cirrhosis , liver disease unrelated underlying metastatic breast cancer . Subject uncontrolled bacterial , viral , fungal infection . Subject exhibit confusion disorientation . Subject condition would prevent adequate followup . Subject receive radiotherapy last 4 week . Subject active primary tumor treatment , except basal cell carcinoma skin , carcinoma situ cervix . Subject brain metastasis . Subject able give inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>